NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|
Total Non-Current Liabilities | ₹3.19 Cr | ₹3.28 Cr | ₹1.79 Cr | ₹1.32 Cr |
What is the latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹3.19 Cr |
Mar2022 | ₹3.28 Cr |
Mar2013 | ₹1.79 Cr |
Mar2012 | ₹1.32 Cr |
How is Total Non-Current Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹3.19 Cr | -2.60 | |
Mar2022 | ₹3.28 Cr | 82.96 | |
Mar2013 | ₹1.79 Cr | 35.20 | |
Mar2012 | ₹1.32 Cr | - |
Compare Total Non-Current Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹383.2 Cr | -2.7% | 10.6% | 24.2% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹10,737.9 Cr | -1.9% | -4.5% | 50.4% | Stock Analytics | |
KAVERI SEED COMPANY | ₹4,308.3 Cr | -4.8% | 29.6% | 59.7% | Stock Analytics | |
VENKYS (INDIA) | ₹2,553.0 Cr | 0.5% | 12.6% | 16.2% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹2,261.9 Cr | -0.8% | -9.2% | -42.6% | Stock Analytics | |
TIERRA AGROTECH | ₹484.3 Cr | 8.2% | 7.6% | -38.6% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -2.7% |
10.6% |
24.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses